Literature DB >> 15915025

Severe pulmonary hypertension during pregnancy: mode of delivery and anesthetic management of 15 consecutive cases.

Martine Bonnin1, Frédéric J Mercier, Olivier Sitbon, Sandrine Roger-Christoph, Xavier Jaïs, Marc Humbert, François Audibert, René Frydman, Gérald Simonneau, Dan Benhamou.   

Abstract

BACKGROUND: Available literature on pregnant women with severe pulmonary hypertension (PH) relies mainly on anecdotal case reports and two series only.
METHODS: The authors reviewed the charts of all pregnant women with severe PH who were followed up at their institution during the past 10 yr, to assess the multidisciplinary treatment and outcome of these patients.
RESULTS: Fifteen pregnancies in 14 women with severe PH were managed during this period: There were 4 cases of idiopathic pulmonary arterial hypertension (PAH), 6 cases of congenital heart disease-associated PAH, 1 case of fenfluramine-associated PAH, 1 case of mixed connective tissue-associated PAH, 1 case of human immunodeficiency virus-associated PAH, and 2 cases of chronic thromboembolic PH. PH presented during pregnancy in 3 patients. Two patients died before delivery at 12 and 23 weeks' gestation. Four patients had vaginal deliveries with regional anesthesia: One died 3 months postpartum, one worsened, and two remained stable. Four had cesarean deliveries during general anesthesia: One died 3 weeks postpartum, one worsened, and two remained stable. Five had cesarean deliveries during low-dose combined spinal-epidural anesthesia: One died 1 week postpartum, and four remained stable. There were two fetal deaths: one related to therapeutic abortion at 21 weeks' gestation and one stillbirth at 36 weeks' gestation followed by the death of the mother 1 week later.
CONCLUSIONS: Despite the most modern treatment efforts, the maternal mortality was 36%. Scheduled cesarean delivery during combined spinal-epidural anesthesia seemed to be an attractive approach, but there was no evidence of actual benefit. Therefore, pregnancy must still be discouraged in patients with severe PH.

Entities:  

Mesh:

Year:  2005        PMID: 15915025     DOI: 10.1097/00000542-200506000-00012

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  44 in total

1.  Challenging cases in rheumatic pregnancies.

Authors:  Cuoghi Edens; Bruna Costa Rodrigues; Marcela Ignacchiti Lacerda; Flavia Cunha Dos Santos; Guilherme R De Jesús; Nilson Ramires De Jesús; Roger A Levy; Cianna Leatherwood; Jess Mandel; Bonnie Bermas
Journal:  Rheumatology (Oxford)       Date:  2018-07-01       Impact factor: 7.580

2.  Effect of steady-state ambrisentan on the pharmacokinetics of a single dose of the oral contraceptive norethindrone (norethisterone) 1 mg/ethinylestradiol 35 microg in healthy subjects: an open-label, single-sequence, single-centre study.

Authors:  Rebecca Spence; Arun Mandagere; Gennyne Walker; Christopher Dufton; Ramesh Boinpally
Journal:  Clin Drug Investig       Date:  2010       Impact factor: 2.859

3.  Update on systemic lupus erythematosus pregnancy.

Authors:  Irene Iozza; Stefano Cianci; Angela Di Natale; Giovanna Garofalo; Anna Maria Giacobbe; Elsa Giorgio; Maria Antonietta De Oronzo; Salvatore Politi
Journal:  J Prenat Med       Date:  2010-10

Review 4.  Treatment of pulmonary arterial hypertension with targeted therapies.

Authors:  Dermot S O'Callaghan; Laurent Savale; David Montani; Xavier Jaïs; Olivier Sitbon; Gérald Simonneau; Marc Humbert
Journal:  Nat Rev Cardiol       Date:  2011-07-19       Impact factor: 32.419

Review 5.  CO and NO pulmonary diffusing capacity during pregnancy: Safety and diagnostic potential.

Authors:  Gerald S Zavorsky; Arlin B Blood; Gordon G Power; Lawrence D Longo; Raul Artal; Emanuel J Vlastos
Journal:  Respir Physiol Neurobiol       Date:  2010-02-10       Impact factor: 1.931

6.  Pulmonary arterial hypertension in the setting of pregnancy: a case series and standard treatment approach.

Authors:  J Shaun Smith; Julianne Mueller; Curt J Daniels
Journal:  Lung       Date:  2011-12-03       Impact factor: 2.584

Review 7.  Pregnancy and pulmonary hypertension: a practical approach to management.

Authors:  David G Kiely; Robin Condliffe; Vicki J Wilson; Suarabh V Gandhi; Charlie A Elliot
Journal:  Obstet Med       Date:  2013-08-08

8.  2014 Guidelines of Taiwan Society of Cardiology (TSOC) for the Management of Pulmonary Arterial Hypertension.

Authors:  Chih-Hsin Hsu; Wan-Jing Ho; Wei-Chun Huang; Yu-Wei Chiu; Tsu-Shiu Hsu; Ping-Hung Kuo; Hsao-Hsun Hsu; Jia-Kan Chang; Chin-Chang Cheng; Chao-Lun Lai; Kae-Woei Liang; Shoa-Lin Lin; Hsao-Hsun Sung; Wei-Chuan Tsai; Ken-Pen Weng; Kai-Sheng Hsieh; Wei-Hsian Yin; Shing-Jong Lin; Kuo-Yang Wang
Journal:  Acta Cardiol Sin       Date:  2014-09       Impact factor: 2.672

9.  Management of pulmonary arterial hypertension during pregnancy: a retrospective, multicenter experience.

Authors:  Alexander G Duarte; Shibu Thomas; Zeenat Safdar; Fernando Torres; Luis D Pacheco; Jeremy Feldman; Bennet deBoisblanc
Journal:  Chest       Date:  2013-05       Impact factor: 9.410

10.  Anaesthesia for caesarean section in the presence of multivalvular heart disease and severe pulmonary hypertension: a case report.

Authors:  Demet Coskun; Ahmet Mahli; Sibel Korkmaz; Figen S Demir; Gozde Karaca Inan; Dilek Erer; M Emin Ozdogan
Journal:  Cases J       Date:  2009-12-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.